Cagle Anthony, McGrath Christine, Richardson Barbra A, Donovan Dennis, Sakr Sameh, Yatich Nelly, Ngomoa Richard, Chepngeno Langat Agnes, John-Stewart Grace, Chung Michael H
a Department of Global Health , University of Washington , Seattle , WA , USA.
b Department Obstetrics & Gynecology , University of Texas Medical Branch , Galveston , TX , USA.
AIDS Care. 2017 Sep;29(9):1192-1197. doi: 10.1080/09540121.2017.1281881. Epub 2017 Jan 29.
Studies on the effects of alcohol use on HIV disease progression have been contradictory, with at least one study finding a positive effect of low alcohol consumption on CD4 count. In addition, most such studies have taken place in the developed West. We investigated the association between alcohol use and immune reconstitution through CD4 count response among HIV-infected individuals on antiretroviral therapy (ART) at an urban sub-Saharan African clinic. This was a retrospective cohort study of treatment-naïve HIV-infected adults initiating ART in Nairobi, Kenya and followed for 12 months between January 2009 and December 2012. At enrollment, a standardized questionnaire was used to collect data on sociodemographic variables and alcohol consumption. CD4 count was measured every six months. Linear regression models assessed the association between CD4 count and alcohol consumption, categorized as abstinent, moderate, or hazardous. Overall, 854 participants were included, 522 of which were women, with 85 (25.6%) men and 50 (9.6%) women reporting any alcohol use, and 8 (2.4%) men and 7 (1.3%) women reporting hazardous drinking. At baseline, alcohol use was associated with higher education and socioeconomic status. Median CD4 count was higher among alcohol users compared to those who abstained at baseline and at 6 and 12 months post-ART initiation, although this was only significant at 6 months. There were no differences in adherence between abstainers and drinkers. While overall alcohol use was significantly associated with higher CD4 counts, moderate and hazardous use treated separately were not. We conclude that, while alcohol use was associated with higher CD4 counts at 12 months post-ART, the mechanism for this association is unclear but may reflect unmeasured socioeconomic or nutritional differences. Additional research is required on the specific drinking patterns of this population and the types of alcoholic beverages consumed to clarify this relationship.
关于饮酒对HIV疾病进展影响的研究结果相互矛盾,至少有一项研究发现少量饮酒对CD4细胞计数有积极影响。此外,大多数此类研究都在西方发达国家进行。我们在撒哈拉以南非洲城市的一家诊所,调查了接受抗逆转录病毒治疗(ART)的HIV感染者中,饮酒与通过CD4细胞计数反应实现的免疫重建之间的关联。这是一项回顾性队列研究,研究对象是肯尼亚内罗毕开始接受ART治疗的初治HIV感染成年人,在2009年1月至2012年12月期间随访12个月。在入组时,使用标准化问卷收集社会人口统计学变量和饮酒情况的数据。每六个月测量一次CD4细胞计数。线性回归模型评估了CD4细胞计数与饮酒之间的关联,饮酒情况分为戒酒、适度饮酒或危险饮酒。总体而言,共纳入854名参与者,其中522名是女性,85名(25.6%)男性和50名(9.6%)女性报告有饮酒行为,8名(2.4%)男性和7名(1.3%)女性报告有危险饮酒行为。在基线时,饮酒与更高的教育程度和社会经济地位相关。与基线时戒酒者以及ART开始后6个月和12个月时戒酒者相比,饮酒者的CD4细胞计数中位数更高,不过仅在6个月时具有统计学意义。戒酒者和饮酒者在依从性方面没有差异。虽然总体饮酒与更高的CD4细胞计数显著相关,但分别来看,适度饮酒和危险饮酒与CD4细胞计数并无关联。我们得出结论,虽然在ART治疗12个月后饮酒与更高的CD4细胞计数相关,但这种关联的机制尚不清楚,可能反映了未测量的社会经济或营养差异。需要对该人群的具体饮酒模式以及所饮用酒精饮料的类型进行更多研究,以阐明这种关系。